Âé¶ą´«Ă˝É«ÇéƬ

Journal News

Computational tool helps scientists create novel bug sprays

Anna Crysler
May 20, 2025

Vector-borne pathogens, or microorganisms carried by insects such as mosquitoes and ticks, lead to . Transmission of these diseases to humans and animals can be mitigated through the application of compounds, commonly known as bug spray, that disrupt an insect’s sense of smell, a phenomenon known as anosmia. Such compounds confuse and block the detection of the host animal. Climate change is thus leading to greater pathogen transmission, signifying a global health threat.

For the past 80 years, DEET, or diethyltoluamide, has dominated the market for insect repellents. Using single compounds for pest repellent can be dangerous because pathogens can develop resistance to the substance. Moreover, with lifestyles moving toward health and sustainability, more people are opting for herbal and natural alternatives instead of synthetic compounds. Identifying natural volatile compounds, or molecules in gas form at room temperature, offers an improvement to current repellents, since skin application is not needed, and natural compounds can be better for health and the environment. However, the discovery processes to generate these molecules are expensive and time-consuming.

Georgia Kythreoti, American College of Greece

, an emeritus research director of the Institute of Biology at the National Center for Scientific Research Demokritos, Greece, and , a research director of the Institute of Chemical Biology at the National Hellenic Research Foundation, created a method to identify naturally occurring insect repellents. In a in the Journal of Biological Chemistry,  and colleagues described a pharmacophore-based screening platform to identify natural compounds that bind mosquito olfactory receptors and cause anosmia.

By scanning hundreds of compounds computationally, the researchers narrowed down their best binders for testing in cells. Specifically, they analyzed how well the odorous ligands interact with a conserved obligatory 7-transmembrane receptor subunit, or ORco, that heteromerizes with odorant recognizing subunits, or ORx, to form olfactory receptors in most mosquitoes.

“The mosquito olfactory system is a bit of a complicated mechanism of signal transduction,” Kythreoti said. The odorous compound must first bind to an odorant-binding protein to interact with the specific receptor(s).

“(The odorant-binding protein) has to capture, solubilize and transfer the odor to the specific receptor heteromer, so this is a very important component,” Zographos said.

Despite their importance, these odorant-binding proteins often differ between insect species. Using the highly conserved ORco receptor in the pharmacophore model offered an improved approach for screening that can identify repellents widely applicable to mosquitoes and a broad range of other insect species important to health and agriculture. The authors validated their model using a collection of olfaction-relevant volatile compounds, including isopropyl cinnamate and linalyl acetate, two known ORco antagonists.

To test the binders generated by the model, researchers inserted a gloved hand into a mesh cage containing hundreds of lab-reared mosquitoes. The glove had an opening, which was surrounded by filter paper loaded with the test compound.  For each trial, the team recorded the number of mosquito landings, an indicator of repellency.

“There is no magical computational tool that can do without the experimental data,” Zographos said. “You need to have good experimental data to train your models in order to go ahead with bigger data sets.”

The researchers will improve the specificity of the model by incorporating different types of data, such as additional structural and 3D data for the binding site, to give rise to rationale design of functional binders.

They hope that their pipeline will accelerate screening for new, functional binders, and their future directions will focus on identifying novel repellent compounds.

“Regardless of a final product or application, as scientists conducting basic research, we aim to contribute knowledge about the mechanisms of insect olfaction to the scientific community,” Zographos said.

Iatrou added: “We provide the tools, and it’s up to other scientists to follow up and develop additional tools that may help to discover new compounds.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anna Crysler

Anna Crysler holds a B.A. in biochemistry from Albion College and is a is a Ph.D. student in bioengineering at the University of Pennsylvania. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.